#124 Ferroptosis Clinical Updates

1.5 CE Total | 1.0 Pharm

This course is now accredited through AANP starting February 18th, 2026

Washington State ND’s: This CME is co-accredited by WANP which allows WA State Category-1 CME Credit for WA Licensed ND’s

Abstract:

Ferroptosis is a relatively new term for a process known to biology for a very long time. It has a better understood pathway and genomic profile than previously understood. In this CME Dr. Anderson will look at the data around this process, what this data adds to our previous knowledge of ‘ferroptosis’ pathways, and how this process may be exploited (or avoided) in disease states. A clinical look at the use of iron to take advantage of ferroptosis and other oxidants (such as artemisinins’, HDIVC, O3 etc.), their appropriateness and uses will be included

Learning Objective:

• Define ferroptosis
• Describe the difference between ferroptosis and other types of cell death
• Define the biochemical triggers of ferroptosis
• Describe the pharmacological manipulation of ferroptosis